Zañudo JGT, Mao P, Alcon C, et al. Cell line-specific network models of ER+ breast cancer identify potential PI3Kα inhibitor resistance mechanisms and drug combinations. Cancer Res. 2021. doi:10.1158/0008-5472.CAN-21-1208
Publications
Collins FS, Schwetz TA, Tabak LA, Lander ES. ARPA-H: Accelerating biomedical breakthroughs. Science. 2021;373(6551):165-167. doi:10.1126/science.abj8547
Delorey TM, Ziegler CGK, Heimberg G, et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature. 2021;595(7865):107-113. doi:10.1038/s41586-021-03570-8
Geiser DM, Al-Hatmi AMS, Aoki T, et al. Phylogenomic Analysis of a 55.1-kb 19-Gene Dataset Resolves a Monophyletic that Includes the Species Complex. Phytopathology. 2021;111(7):1064-1079. doi:10.1094/PHYTO-08-20-0330-LE
Doan M, Barnes C, McQuin C, et al. Deepometry, a framework for applying supervised and weakly supervised deep learning to imaging cytometry. Nat Protoc. 2021;16(7):3572-3595. doi:10.1038/s41596-021-00549-7
Tomov ML, O’Neil A, Abbasi HS, et al. Resolving cell state in iPSC-derived human neural samples with multiplexed fluorescence imaging. Commun Biol. 2021;4(1):786. doi:10.1038/s42003-021-02276-x
Awad MM, Liu S, Rybkin II, et al. Acquired Resistance to KRAS Inhibition in Cancer. N Engl J Med. 2021;384(25):2382-2393. doi:10.1056/NEJMoa2105281
Taylor HB, Klaeger S, Clauser KR, et al. Mass spectrometry-based HLA-II peptidomics combined with multi-omics will aid the development of future immunotherapies. Mol Cell Proteomics. 2021:100116. doi:10.1016/j.mcpro.2021.100116
Adane B, Alexe G, Seong BKA, et al. STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma. Cancer Cell. 2021;39(6):827-844.e10. doi:10.1016/j.ccell.2021.05.007
Cruz DL, Pipalia N, Mao S, et al. Inhibition of Histone Deacetylases 1, 2, and 3 Enhances Clearance of Cholesterol Accumulation in Niemann-Pick C1 Fibroblasts. ACS Pharmacol Transl Sci. 2021;4(3):1136-1148. doi:10.1021/acsptsci.1c00033